| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |